• PDF: Delivered by email usually within 4 to 8 UK business hours.

Puerto Rico Pharmaceuticals and Healthcare Report Q3 2013

  • Publication Date:July 2013
  • Publisher:Business Monitor
  • Product Type: Report
  • Pages:97
  • ISBN:135225

Puerto Rico Pharmaceuticals and Healthcare Report Q3 2013

Includes 3 FREE quarterly updates

BMI View: The loss of confidence in the key pharmaceutical sector is expected to impact consumption levels directly. The fate of the Puerto Rican pharmaceutical market will also remain closely tied to its economy, given that the US remains its key export partner. Nevertheless, we expect volume consumption to continue boosting the pharmaceutical sales value in the territory, especially as the effect of patent expirations gradually wears off.

Headline Expenditure Projections

- Pharmaceuticals: US$2.92bn in 2012 to US$3.05bn in 2013; +4.4% in local currency terms. Forecast broadly in line with the previous quarter's figures.
- Healthcare: US$7.53bn in 2012 to US$7.81bn in 2013; +3.7% in local currency terms. Forecast unchanged from the previous quarter.
BMI Industry View 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Puerto Rico Pharmaceutical Sales, Historical Data and Forecasts 12
Healthcare Market Forecast 13
Table: Puerto Rico Healthcare Expenditure Trends, Historical Data and Forecasts 14
Prescription Drug Market Forecast 15
Table: Puerto Rico Prescription Drug Market Indicators, Historical Data and Forecasts 16
Patented Drug Market Forecast 16
Table: Puerto Rico Patented Drug Market Indicators, Historical Data and Forecasts 17
Generic Drug Market Forecast 18
Table: Puerto Rico Generics Drug Market Indicators, Historical Data and Forecasts 19
OTC Medicine Market Forecast 19
Table: Puerto Rico Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 20
Pharmaceutical Trade 21
Table: Puerto Rico Pharmaceutical Trade Data And Forecasts (USDmn) 24
Other Healthcare Data 24
Key Risks To BMI's Forecast Scenario 24
Macroeconomic Forecasts 26
Economic Activity 26
Table: Puerto Rico - Economic Activity 28
Industry Risk Reward Ratings 29
Americas Risk/Reward Ratings 29
Puerto Rico Risk/Reward Ratings 34
Market Overview 36
Industry Trends And Developments 37
Regulatory Development 49
Table: Incentives, Benefits And Discounts For Pharmaceutical Manufacturers 52
Competitive Landscape 55
Table: Major International Drugmakers In Puerto Rico 57
Table: Puerto Rico Continues To Attract Foreign Investment, Despite Challenges 61
Table: Puerto Rico: Multinational Downscaling 63
Company Profile 68
Pfizer 68
GlaxoSmithKline 70
Merck & Co 72
Abbott Laboratories 75
Novartis 78
Sanofi-Aventis 80
Eli Lilly 82
Johnson & Johnson (J&J) 85
Demographic Forecast 89
Puerto Rico 89
Table: Puerto Rico's Population By Age Group, 1990-2020 ('000) 90
Table: Puerto Rico's Key Population Ratios, 1990-2020 92
Table: Puerto Rico's Rural And Urban Population, 1990-2020 92
Glossary 93
Methodology 95
Pharmaceutical Expenditure Forecast Model 95
Healthcare Expenditure Forecast Model 95
Notes On Methodology 96
+44 20 8816 8548

Ask a question about Puerto Rico Pharmaceuticals and Healthcare Report Q3 2013

Enter the characters you see in the picture below
Captcha